Home/Filings/4/0001457612-16-000040
4//SEC Filing

GENOCEA BIOSCIENCES, INC. 4

Accession 0001457612-16-000040

CIK 0001457612operating

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:31 PM ET

Size

5.3 KB

Accession

0001457612-16-000040

Insider Transaction Report

Form 4
Period: 2016-02-02
HETHERINGTON SETH V
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2016-02-02+100,000100,000 total
    Exercise: $3.09Exp: 2026-02-01Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.

Issuer

GENOCEA BIOSCIENCES, INC.

CIK 0001457612

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001457612

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:31 PM ET
Size
5.3 KB